I-Mab Biopharma
IMAB
#9469
Rank
A$91.66 M
Marketcap
$1.12
Share price
-6.87%
Change (1 day)
-58.84%
Change (1 year)

I-Mab Biopharma (IMAB) - Total debt

Total debt on the balance sheet as of September 2024 : A$6.25 Million

According to I-Mab Biopharma's latest financial reports the company's total debt is A$6.25 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

I-Mab Biopharma - Total debt on balance sheet (from 2024 to 2023)

Total debt by year

Year Total debt Change
2023-12-31A$3.92 M69.34%
2022-12-31A$2.31 M-39.36%
2021-12-31A$3.81 M820.08%
2020-12-31A$0.41 M-89.28%
2019-12-31A$3.87 M-12.23%
2018-12-31A$4.41 M-31.32%
2017-12-31A$6.42 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.83 B 13,241.55%๐Ÿ‡บ๐Ÿ‡ธ USA